Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who are able to give their informed consent to participate
- People who are willing and able to attend a study visit at the Centre for Eye Research Australia
- People who have been diagnosed with a retinal or optic nerve disease, such as diabetic retinopathy, glaucoma, or age-related macular degeneration
- Healthy people without any known retinal or optic nerve disease, who are matched by age and sex to participants with a diagnosed condition
Who may not be able to join:
- People who are unable to give informed consent
- People with eye conditions that would prevent clear retinal imaging, such as a dense cataract, significant cloudiness of the cornea, or bleeding inside the eye
- People with a known medical reason why eye drops used to widen the pupil would not be safe for them
- People with a history of a narrow drainage angle in the eye, or who are considered at risk of a type of glaucoma that could be triggered by pupil dilation
- People with any other condition that the trial investigator believes could affect their safety or the quality of the images taken
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +61 3 9959 0102
Australian sites
+61 3 9959 0102
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Diagnostic performance of hyperspectral imaging-derived spectral score for detection of retinal disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.